Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Placebo-controlled, Multi-country & Multi-center Study to Assess the Efficacy, Safety & Immunogenicity of 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00140673
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:27.562743+00:00
Published At
2019-12-30T00:00:00+00:00
Record Updated At
2019-12-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Infections, Rotavirus"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-12-30"
protocolSection.identificationModule.nctId
"NCT00140673"
protocolSection.identificationModule.officialTitle
"A Placebo-controlled, Multi-country \u0026 Multi-center Study to Assess the Efficacy, Safety \u0026 Immunogenicity of 2 Doses of GSK Biologicals\u0027 Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Infections, Rotavirus (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.